Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism CGAS agonists(cyclic GMP-AMP synthase agonists), STING agonists(Stimulator of interferon genes agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H16O8 |
InChIKeyDOUMFZQKYFQNTF-WUTVXBCWSA-N |
CAS Registry20283-92-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis | Preclinical | China | 24 Jun 2025 | |
Squamous cell carcinoma of the oral cavity | Preclinical | Portugal | 01 Jun 2025 | |
Pseudorabies | Preclinical | China | 17 Mar 2025 | |
Triple Negative Breast Cancer | Preclinical | China | 25 Feb 2025 | |
Triple Negative Breast Cancer | Preclinical | China | 25 Feb 2025 |